Resources

Filter by:
Or browse by popular tag:
Educational Videos, Explainer Videos

Peptide receptor radionuclide therapy (PRRT)

Clinical Trials

Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients

The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Causes & Risk Factors

Potential Carcinogens and Neuroendocrine Tumour Risk

Wellness

Problem-Solving during a Neuroendocrine Cancer Diagnosis

Prognosis

Prognosis in Rare and Aggressive Neuroendocrine Cancers

Educational Videos

PRRT Demystified, presented by Dr Natalia Kovaleva

Educational Videos, Forum Videos

PRRT presented by Dr Aviral Singh

NET Patient Forum Perth - PRRT presented by Dr Aviral Singh

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.